Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XO1O
|
|||
| Drug Name |
CC8464
|
|||
| Synonyms |
ASP1807
Click to Show/Hide
|
|||
| Indication | Neuropathic pain [ICD-11: 8E43.0] | Phase 1 | [1] | |
| Pain [ICD-11: MG30-MG3Z] | Phase 1 | [2] | ||
| Company |
Astellas Northbrook, IL Chromocell North Brunswick, NJ
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target Info | Inhibitor | [1] |
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.